Ausgabe 12/2006
Inhalt (15 Artikel)
Survival benefit associated with human anti-mouse antibody (HAMA) in patients with B-cell malignancies
Ignacio Azinovic, Gerald L. DeNardo, Kathleen R. Lamborn, Gary Mirick, Desiree Goldstein, Bonnie M. Bradt, Sally J. DeNardo
Increased liver temperature efficiently augments human cellular immune response: T-cell activation and possible monocyte translocation
Yohei Kida, Sachiyo Tsuji-Kawahara, Valentina Ostapenko, Saori Kinoshita, Eiji Kajiwara, Hiroyuki Kawabata, Takae Yuasa, Iwao Nishide, Susumu Yukawa, Masakazu Ichinose, Masaaki Miyazawa
Mechanism of action differences in the antitumor effects of transmembrane and secretory tumor necrosis factor-alpha in vitro and in vivo
Qingfen Li, Li Li, Wenfang Shi, Xiaodan Jiang, Yong Xu, Feili Gong, Muxiang Zhou, Carl K. Edwards III, Zhuoya Li
In vitro priming of tumor-specific cytotoxic T lymphocytes using allogeneic dendritic cells derived from the human MUTZ-3 cell line
Saskia J. A. M. Santegoets, Marco W. J. Schreurs, Allan J. Masterson, Ying Poi Liu, Steffen Goletz, Hans Baumeister, Esther W. M. Kueter, Sinéad M. Lougheed, Alfons J. M. van den Eertwegh, Rik J. Scheper, Erik Hooijberg, Tanja D. de Gruijl
Antitumor effects of a xenogeneic survivin bone marrow derived dendritic cell vaccine against murine GL261 gliomas
Michael J. Ciesielski, Lisa Apfel, Tara A. Barone, Carla A. Castro, Tina C. Weiss, Robert A. Fenstermaker
A mechanistic study of immune system activation by fusion of antigens with the ligand-binding domain of CTLA4
Dhanalakshmi Chinnasamy, Matt Tector, Nachimuthu Chinnasamy, Kate Dennert, Karen M. Kozinski, Martin K. Oaks
STEAP, a prostate tumor antigen, is a target of human CD8+ T cells
Pedro M. S. Alves, Olivier Faure, Stéphanie Graff-Dubois, Sebastien Cornet, Irena Bolonakis, David-Alexandre Gross, Isabelle Miconnet, Salem Chouaib, Karim Fizazi, Jean Charles Soria, François A. Lemonnier, Kostas Kosmatopoulos
Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma
Ying Waeckerle-Men, Edith Uetz-von Allmen, Markus Fopp, Roger von Moos, Christel Böhme, Hans-Peter Schmid, Daniel Ackermann, Thomas Cerny, Burkhard Ludewig, Marcus Groettrup, Silke Gillessen
Macrophage inflammatory protein (MIP)1α and MIP1β differentially regulate release of inflammatory cytokines and generation of tumoricidal monocytes in malignancy
Anamika Nath, Sreya Chattopadhya, Utpala Chattopadhyay, Nawal K. Sharma
CD40 ligation restores cytolytic T lymphocyte response and eliminates fibrosarcoma in the peritoneum of mice lacking CD4+ T cells
Andrew Lodge, Ping Yu, Michael B. Nicholl, Ian E. Brown, Carl-Christian A. Jackson, Karin Schreiber, Sonia L. Sugg, Hans Schreiber, Joel Shilyansky
Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancer
Paal F. Brunsvig, Steinar Aamdal, Marianne K. Gjertsen, Gunnar Kvalheim, Carrie J. Markowski-Grimsrud, Ingunn Sve, Marianne Dyrhaug, Sissel Trachsel, Mona Møller, Jon A. Eriksen, Gustav Gaudernack
Endoglin (CD105) is a target for an oral DNA vaccine against breast cancer
Sung-Hyung Lee, Noriko Mizutani, Masato Mizutani, Yunping Luo, He Zhou, Charles Kaplan, Sung-Woo Kim, Rong Xiang, Ralph A. Reisfeld
Identification of a new HLA-A*0201-restricted cytotoxic T lymphocyte epitope from CML28
Jun-Feng Han, Ting-Ting Zhao, Hong-Li Liu, Zhi-Hua Lin, Hui-Ming Wang, Zhi-Hua Ruan, Li-Yun Zou, Yu-Zhang Wu
Soluble MICB in malignant diseases: analysis of diagnostic significance and correlation with soluble MICA
Stefan Holdenrieder, Petra Stieber, Andrea Peterfi, Dorothea Nagel, Alexander Steinle, Helmut Rainer Salih
Target-selective activation of a TNF prodrug by urokinase-type plasminogen activator (uPA) mediated proteolytic processing at the cell surface
Jeannette Gerspach, Julia Németh, Sabine Münkel, Harald Wajant, Klaus Pfizenmaier